Skip to main content
OpenTrials

Clinical trial condition

Lipid Metabolism, Inborn Errors

Explore clinical trials studying Lipid Metabolism, Inborn Errors. Study availability and eligibility vary by location and protocol.

834 public trials 155 recruiting studies
Refine in advanced search Browse all conditions

Lipid Metabolism, Inborn Errors trial results

Completed

Switch Over Study of Biosimilar Agalsidase Beta for Fabry Disease

NCT05843916

Conditions
Brain Diseases, Brain Diseases, Metabolic, Brain Diseases, Metabolic, Inborn, +19 more
Locations
  • Instituto de Nefrología Pergamino S.R.L Pergamino, Buenos Aires, Argentina
  • Centro Médico Santa María de la Salud San Isidro, Buenos Aires, Argentina
  • Instituto de Investigaciones Clínicas Quilmes Buenos Aires, Argentina
  • Clínica Universitaria Reina Fabiola Córdoba, Argentina
View Trial Details
Completed

Safety, Pharmacodynamics, and Efficacy of Migalastat in Pediatric Subjects (Aged >12 Years) With Fabry Disease

NCT04049760

Conditions
Brain Diseases, Brain Diseases, Metabolic, Brain Diseases, Metabolic, Inborn, +19 more
Locations
  • University of South Florida Tampa, Florida, United States
  • The Emory Clinic Atlanta, Georgia, United States
  • University of Minnesota Masonic Children's Hospital and Clinics Minneapolis, Minnesota, United States
  • Cincinnati Children's Hospital Cincinnati, Ohio, United States
View Trial Details
Completed

A Study to Describe the Experience of Both Patients and Their Clinicians in the Treatment of Fabry Disease With Enzyme Replacement Therapy.

NCT04281537

Conditions
Brain Diseases, Brain Diseases, Metabolic, Brain Diseases, Metabolic, Inborn, +19 more
Locations
  • Amicus Therapeutics, Inc. Philadelphia, Pennsylvania, United States
  • Instituto de Genética e Erros Inatos do Metabolismo (IGEIM) São Paulo, Brazil
  • Keio University Hospital Tokyo, Japan
  • Yokohama Municipal Citizen's Hospital Yokohama, Japan
View Trial Details
Completed

Study to Evaluate Efficacy and Safety of Inclisiran in Adolescents With Homozygous Familial Hypercholesterolemia

NCT04659863

Conditions
Congenital, Hereditary, and Neonatal Diseases and Abnormalities, Dyslipidemias, Familial Hypercholesterolemia - Homozygous, +10 more
Locations
  • Excel Medical Clinical Trials LLC Boca Raton, Florida, United States
  • Novartis Investigative Site Québec, Quebec, Canada
  • Novartis Investigative Site Bron, France
  • University General Hospital of Ioannina Ioannina, GR, Greece
View Trial Details
Completed

Brazilian Cardioprotective Diet, Phytosterols and Krill Oil in Patients With Familial Hypercholesterolemia

NCT05695937

Conditions
Congenital, Hereditary, and Neonatal Diseases and Abnormalities, Dyslipidemias, Familial Hypercholesterolemia, +9 more
Locations
  • Hospital São José Criciúma, Brazil
  • Hospital das Clínicas da Universidade Federal de Goiás Goiânia, Brazil
  • Universidade Regional do Noroeste do Estado do Rio Grande do Sul Ijuí, Brazil
  • Instituto Nacional de Cardiologia Rio de Janeiro, Brazil
View Trial Details
Completed

Study of ARO-ANG3 in Healthy Volunteers and in Dyslipidemic Patients

NCT03747224

Conditions
Congenital, Hereditary, and Neonatal Diseases and Abnormalities, Dyslipidemias, Familial Hypercholesterolemia, +10 more
Locations
  • Research Site 2 Camperdown, New South Wales, Australia
  • Research Site 3 Adelaide, South Australia, Australia
  • Research Site 1 Nedlands, Australia
  • Research Site 4 Grafton, Auckland, New Zealand
View Trial Details
Completed

Study of ARO-APOC3 in Healthy Volunteers, Hypertriglyceridemic Patients and Patients With Familial Chylomicronemia Syndrome (FCS)

NCT03783377

Conditions
Congenital, Hereditary, and Neonatal Diseases and Abnormalities, Dyslipidemias, Familial Chylomicronemia, +10 more
Locations
  • Research Site 2 Camperdown, New South Wales, Australia
  • Research Site 5 Sippy Downs, Queensland, Australia
  • Research Site 3 Adelaide, South Australia, Australia
  • Research Site 4 Perth, Washington, Australia
View Trial Details

Related conditions